Pharmacology of competitive inhibitors of HMG-CoA reductase

Pharmacol Res. 1995 Jan;31(1):9-27. doi: 10.1016/1043-6618(95)80042-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / prevention & control
  • Cattle
  • Cells, Cultured / drug effects
  • Chick Embryo
  • Cholesterol / biosynthesis*
  • Cholesterol / blood
  • Cricetinae
  • Dogs
  • Guinea Pigs
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Lipid Metabolism
  • Lipids / blood
  • Lipoproteins / drug effects
  • Lovastatin / analogs & derivatives
  • Lovastatin / pharmacology
  • Mevalonic Acid / metabolism
  • Mice
  • Organ Specificity
  • Rabbits
  • Rats
  • Simvastatin

Substances

  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • Lipoproteins
  • Cholesterol
  • Lovastatin
  • Simvastatin
  • Mevalonic Acid